Using quantitative systems pharmacology modeling to optimize combination therapy of anti-PD-L1 checkpoint inhibitor and T cell engager
Published: 13 June 2023| Version 1 | DOI: 10.17632/crk9tmnmb7.1
Contributors:Samira Anbari, Hanwen Wang, Yu Zhang, Jun Wang, Minu Pilvankar, Masoud Nickaeen, Steven Hansel, Aleksander S. Popel
This repository contains the QSP platform for combination therapy of anti-PD-L1 checkpoint inhibitor and T cell engager developed by the Popel Systems Biology Laboratory. https://popellab.johnshopkins.edu/.
Steps to reproduce
Refer to the readme file
Johns Hopkins University
Mathematical Modeling, Pharmacodynamics, Pharmacokinetics, Cancer Immunotherapy